Commentary | Published:

Changes in the business of culture

Nature Biotechnology volume 22, pages 13551356 (2004) | Download Citation


Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Pharmaceutical outsourcing opportunities post launch. in Kalorama Information Market Intelligence (ed. Heffner, S.) (New York, 2004).

  2. 2.

    Bioprocess International. Protein Expression in the 21st Century. Bioprocess International Supplement Series (Bioprocess International, Eugene, OR, 2004).

  3. 3.

    et al. in Mckinsey Quarterly 2002 Special Edition: Risk and Resilience. 9–11 (McKinsey, New York, 2002).

  4. 4.

    European Parliament and European Council. Off. J. Eur. Commun. L121, 34–44 (2001).

  5. 5.

    BioCentury August 2, A1–A10 (2004).

  6. 6.

    Bioprocess International 2, 26–30 (2004).

Download references

Author information


  1. Pedro de Noronha Pissarra is at Biotecnol SA, Taguspark, Edifício Inovação 4, No. 809, 2780-920 Oeiras, Portugal.

    • Pedro de Noronha Pissarra


  1. Search for Pedro de Noronha Pissarra in:

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing